Skip to main content
OpenTrials

Clinical trial condition

Hyperphosphatemia

Explore clinical trials studying Hyperphosphatemia. Study availability and eligibility vary by location and protocol.

95 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hyperphosphatemia trial results

Completed

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

NCT03824587

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Nephrology Consultants, LLC Huntsville, Alabama, United States
  • US Renal Care Pine Bluff Pine Bluff, Arkansas, United States
  • Southeast Renal Research Beverly Hills, California, United States
  • California Institute of Renal Research - Chula Vista Chula Vista, California, United States
View all 48 locations
View Trial Details
Completed

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

NCT04922645

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron Deficiency, +16 more
Locations
  • US Renal Care - Dimond Anchorage, Alaska, United States
  • US Renal Care - Mesa Mesa, Arizona, United States
  • US Renal Care - Pine Bluff Pine Bluff, Arkansas, United States
  • US Renal Care - Northridge Roscoe Granada Hills, California, United States
View all 13 locations
View Trial Details
Completed

A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients

NCT04551300

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Zhongshan Hospital Xiamen University Xiamen, Fujian, China
  • Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
View all 23 locations
View Trial Details
Completed

Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China

NCT03001011

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Investigational Site Number 1560003 Beijing, China
  • Investigational Site Number 1560026 Cangzhou, China
  • Investigational Site Number 1560015 Changchun, China
  • Investigational Site Number 1560011 Changsha, China
View all 38 locations
View Trial Details

Related conditions